Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Ovarian Neoplasms × neratinib × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Recurrence 1 Ovarian Neoplasms 1 Neuroma, Acoustic 1 Neurofibromatosis 2 1 Neoplasm Metastasis 1 Meningioma 1 Lymphoma 1 Leukemia 1 Ependymoma 1 Disease 1 Central Nervous System Neoplasms 1

Interventions

pembrolizumab 24 Paclitaxel 20 Carboplatin 20 olaparib 19 Bevacizumab 13 Magnetic Resonance Spectroscopy 11 Gemcitabine 11 Taxes 10 Nivolumab 10 Cyclophosphamide 10 niraparib 9 Specimen Handling 8 Biopsy 8 liposomal doxorubicin 5 fludarabine 5 durvalumab 5 Surveys and Questionnaires 5 Immunoglobulin G 5 Doxorubicin 5 Disulfides 5 Cisplatin 5 Letrozole 4 Ipilimumab 4 palbociclib 3 oregovomab 3 cediranib 3 atezolizumab 3 X-Rays 3 Pemetrexed 3 Oxaliplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04502602 2025-05-04

iNNOVATE

Virginia Commonwealth University

Phase 1 Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡